Black Diamond Therapeutics
BDTX
BDTX
68 hedge funds and large institutions have $36.3M invested in Black Diamond Therapeutics in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
52% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 25
Holders
68
Holding in Top 10
–
Calls
$844K
Puts
$807K
Top Buyers
| 1 | +$885K | |
| 2 | +$544K | |
| 3 | +$168K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$156K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$119K |
Top Sellers
| 1 | -$598K | |
| 2 | -$518K | |
| 3 | -$288K | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$180K |
| 5 |
E
Ergoteles
New York
|
-$101K |